Your Goals. Your Journey.

Tirzepatide is a once-weekly injectable medication that activates two hormone receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Key effects: It is approved for type 2 diabetes and, under specific brand indications, for chronic weight management in eligible adults. Common side effects include nausea, diarrhea, vomiting, constipation, and decreased appetite. In simple terms: Tirzepatide works on two metabolic pathways at once to help control blood glucose and reduce appetite, making it a powerful tool for diabetes management and weight loss.   Complete kit includes: Tirzepatide vial, 3ml bacteriostatic water, insulin syringes, reconstitution syringe, QR for protocol guide, alcohol pads and packaging.

Tirzepatide is a once-weekly injectable medication that activates two hormone receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). It is approved for type 2 diabetes and, under specific brand indications, for chronic weight management in eligible adults. Common side effects include nausea, diarrhea, vomiting, constipation, and decreased appetite. In simple terms: Tirzepatide works on two metabolic pathways at once to help control blood glucose and reduce appetite, making it a powerful tool for diabetes management and weight loss.   Complete kit includes: Tirzepatide vial, 3ml bacteriostatic water, insulin syringes, reconstitution syringe, QR for protocol guide, alcohol pads and packaging.

Retatrutide is an investigational once-weekly injectable peptide being studied for obesity and metabolic disease. It activates three hormone receptors: GLP-1 – helps reduce appetite and food intake, GIP – supports metabolic and glucose regulation and Glucagon – may increase energy expenditure and influence fat metabolism. Complete kit includes: Retatrutide vial, 3ml bacteriostatic water, insulin syringes, reconstitution syringe, QR for protocol guide, alcohol pads and packaging.